Evidence map›Paper›PMID 35603181›Full record

ArticleFrontiers in immunology2022

GATA2 Deficiency in Adult Life Is Characterized by Phenotypic Diversity and Delayed Diagnosis.

Oded Shamriz, Naseem Zahalka, Amos J Simon, Atar Lev, Ortal Barel, Nofar Mor, Yuval Tal, Michael J Segel, Raz Somech, Hagith Yonath and 1 more

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.1field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Oded ShamrizAllergy and Clinical Immunology Unit, Department of Medicine, Hadassah Medical Organization, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
Naseem ZahalkaInternal Medicine A, Sheba Medical Center, Ramat Gan, Israel.
Amos J SimonSheba Cancer Research Center and Institute of Hematology, Sheba Medical Center, Ramat Gan, Israel.
Atar LevPediatric Department A and the Immunology Service, Jeffrey Modell Foundation Center, Edmond and Lily Safra Children's Hospital, Tel-Hashomer Medical Center, Affiliated to the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Ortal BarelThe Genomic Unit, Sheba Cancer Research Center, Sheba Medical Center, Ramat Gan, Israel.
Nofar MorThe Genomic Unit, Sheba Cancer Research Center, Sheba Medical Center, Ramat Gan, Israel.
Yuval TalAllergy and Clinical Immunology Unit, Department of Medicine, Hadassah Medical Organization, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
Michael J SegelSackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Raz SomechPediatric Department A and the Immunology Service, Jeffrey Modell Foundation Center, Edmond and Lily Safra Children's Hospital, Tel-Hashomer Medical Center, Affiliated to the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Hagith YonathInternal Medicine A, Sheba Medical Center, Ramat Gan, Israel.
Ori TokerAllergy and Clinical Immunology Unit, Shaare Zedek Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
Sheba Medical Center · ILHebrew University of Jerusalem · ILEdmond and Lily Safra Children's Hospital · ILJeffrey Modell Foundation · USTel Aviv University · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The transcription factor GATA2 plays a key role in the survival and self-renewal of hematopoietic stem and progenitor cells. Autosomal dominant variants in

Indexed as

GATA2 DeficiencyMyelodysplastic SyndromesBone MarrowDelayed DiagnosisFemaleGATA2 Transcription FactorHumansMalePhenotypeGATA2 protein, humanGATA2 Transcription FactordiagnosisexomeGATA2hematopoieticprimary immune deficiency (PID)

Identifiers

PMID35603181
PMCPMC9120659
OpenAlexW4229065629

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.